Adhesion molecules: A rheumatologic perspective

Arthritis and Rheumatism

Volumn 40, Issue 6, 1997, Pages 991-1004

  Mojcik, Christopher F ^a   Shevach, Ethan M ^b  

^a BAYER CORPORATION   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; SELECTIN; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN RECOGNITION; CELL ADHESION; CELL MIGRATION; DENDRITIC CELL; ENDOTHELIUM CELL; HUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; STEM CELL; TARGET CELL; VASCULAR ENDOTHELIUM;

ARTHRITIS, RHEUMATOID; CELL ADHESION MOLECULES; HUMANS;

EID: 0030992610     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400602     Document Type: Review

References (164)

1. Hemler ME: VLA proteins in the integrin family: structures, functions and their roles on leukocytes. Annu Rev Immunol 8:365-400, 1990
2. Springer TA: Adhesion receptors of the immune system. Nature 346:425-434, 1990
3. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992
4. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314, 1994
5. Lobb RR, Hemler ME: The pathophysiologic role of α4 integrins in vivo. J Clin Invest 94:1722-1728, 1994
6. Cronstein BN, Weissmann G: The adhesion molecules of inflammation. Arthritis Rheum 36:147-157, 1993
7. Postigo AA, Rosario G-V, Laffon A, Sanchez-Madrid F: The role of adhesion molecules in the pathogenesis of rheumatoid arthritis. Autoimmunity 16:69-76, 1993
8. Chapman PT, Haskard DO: Leukocyte adhesion molecules. Br Med Bull 51:296-311, 1995
9. Lasky LA: Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258:964-969, 1992
10. Rosen SD: L-selectin and its biological ligands. Histochemistry 100:185-191, 1993
11. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B: Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and leetins. Science 243:1160-1165, 1989
12. Lozada C, Levin RI, Huie M, Hirschhorn R, Naime D, Whitlow M, Recht PA, Golden B, Cronstein BN: Identification of C1q as the heat labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc Natl Acad Sci U S A 92:8378-8382, 1995
13. Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L: Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 182:1857-1864, 1995
14. Vestweber D: Selectins: cell surface lectins which mediate the binding of leukocytes to endothelial cells. Semin Cell Biol 3:211-220, 1992
15. Gallatin WM, Weissman IL, Butcher EC: A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30-34, 1983
16. Von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors K-E, Butcher EC: Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo. Proc Natl Acad Sci U S A 88:7538-7542, 1991
17. Berg M, James SP: Human neutrophils release the Leu-8 lymph node homing receptor during cell activation. Blood 76:2381-2388, 1990
18. Lasky LA, Singer MS, Dowbenko D, Imai Y, Henzel WJ, Grimley C, Fennie C, Gillett N, Watson SR, Rosen SD: An endothelial ligand for L-selectin is a novel mucin-like molecule. Cell 69:927-938, 1992
19. Michie SA, Streeter PR, Bolt PA, Butcher EC, Picker LJ: The human peripheral lymph node vascular addressin: an inducible endothelial antigen involved in lymphocyte homing. Am J Pathol 143:1688-1698, 1993
20. Baumhueter S, Singer MS, Henzel W. Hemmerich S, Renz M, Rosen SD, Lasky LA: Binding of L-selectin to the vascular sialomucin CD34. Science 262:436-438, 1993
21. Berg EL, McEvoy LM, Berlin C, Bargatze RF, Butcher EC: L-selectin-mediated lymphocyte rolling on MAdCAM-1. Nature 366:695-698, 1993
22. Briskin MJ, McEvoy LM, Butcher EC: MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature 363:461-464, 1993
23. Sanchez-Madrid F, Corbi AL: Leukocyte integrins: structure, function and regulation of their activity. Semin Cell Biol 3:199-210, 1992
24. Mojcik CF, Salomon DR, Chang AC, Shevach EM: Differential expression of integrins on human thymocyte subpopulations. Blood 86:4206-4217, 1995
25. Elices MJ, Osborn L, Takada Y, Crouse C Luhowskyj S, Hemler ME, Lob RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/ fibronectin binding site. Cell 60:577-584, 1990
26. Strauch UG, Lifka A, Gosslar U, Kilshaw PJ, Clements J, Holzmann B: Distinct binding specificities of integrins α4β7 (LPAM-1), α4β1 (VLA-4), and αIELβ7. Int Immunol 6:263-275, 1994
27. Andrew DP, Berlin C, Honda S, Yoshino T, Hamann A, Holzmann BH, Kilshaw PJ, Butcher EC: Distinct but overlapping epitopes are involved in α4β7-mediated adhesion to vascular cell adhesion molecule-1, mucosal addressin-1, fibronectin, and lymphocyte aggregation. J Immunol 153:3847-3861, 1994
28. Shimizu Y, van Seventer GA, Horgan KJ, Shaw S: Regulated expression and binding of three VLA (β1) integrin receptors on T cells. Nature 345:250-253, 1990
29. Chan BMC, Wong JGP, Rao A, Hemler ME: T cell receptor-dependent, antigen-specific stimulation of a murine T cell clone induces a transient, VLA protein-mediated binding to extracellular matrix. J Immunol 147:398-404, 1991
30. Lloyd AR, Oppenheim JJ, Kelvin KJ, Taub DD: Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J Immunol 156:932-938, 1996
31. Masumoto A, Hemler ME: Multiple activation stales of VLA-4: mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J Biol Chem 268:228-234, 1993
32. Shimizu Y, Mobley JL: Distinct divalent cation requirements of integrin-mediated CD4+ T lymphocyte adhesion to ICAM-1, fibronectin, VCAM-1, and invasin. J Immunol 151:4106-4115, 1993
33. Buck CA: Immunoglobulin superfamily: structure, function and relationship to other receptor molecules. Semin Cell Biol 3:179-188, 1992
34. Rice GE, Munro JM, Bevilacqua MP: Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes: a CD11/CD18-independent adhesion mechanism. J Exp Med 171:1369-1374, 1990
35. Piali L, Hammel P, Uherek C, Bachmann F, Gisler RH, Dunon D, Imhof BA: CD31/PECAM-1 is a ligand for αv/β3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 130:451-560, 1995
36. Bradley LM, Watson SR: Lymphocyte migration into tissue: the paradigm derived from CD4 subsets. Curr Opin Immunol 8:312-320, 1996
37. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 272:60-66, 1996
38. Mackay CR: T-cell memory: the connection between function, phenotype and migration pathways. Immunol Today 12:189-192, 1991
39. Damle NK, Doyle LV: Ability of human T lymphocytes to adhere to vascular endothelial cells and to augment endothelial permeability to macromolecules is linked to their state of post-thymic maturation. J Immunol 144:1233-1240, 1990
40. Butcher EC: Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033-1036, 1991
41. Ley K, Gaehtgens P, Fennie C, Singer MS, Lasky LA, Rosen SD: Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo. Blood 77:2553-2555, 1991
42. Arbones ML, Ord DC, Ley K. Rathech H, Maynard-Curry C, Otten G, Capon DJ, Tedder TF: Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1:247-260, 1994
43. Watson SR, Fennie C, Lasky LA: Neutrophil influx into an inflammatory site inhibited by a soluble homing receptor-IgG chimaera. Nature 349:164-167, 1991
44. Issekutz TB: Effect of antigen challenge on lymph node lymphocyte adhesion to vascular endothelial cells and the role of VLA-4 in the rat. Cell Immunol 138:300-312, 1991
45. Muller WA, Weigl SA, Deng X, Phillips DM: PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178:449-460, 1993
46. Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hassien SR, Nelson RD, Berg EL, Erlandsen SL, Butcher EC: α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413-422, 1995
47. Meerschaert J, Furie MB: Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro. J Immunol 152:1915-1926, 1994
48. Girard J-P, Springer TA: High endothelial venutes (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 16:449-457, 1995
49. Iguchi T, Ziff M: Electron microscopic study of rheumatoid synovial vasculature: intimate relationship between tall endothelium and lymphoid aggregates. J Clin Invest 77:355-361, 1986
50. Van Dinther-Janssen ACHM, Pals ST, Scheper RJ, Meijer CJLM: Role of the CS1 adhesion motif of fibronectin in T cell adhesion to synovial membrane and peripheral lymph node endothelium. Ann Rheum Dis 52:672-676, 1993
51. Hamann A, Andrew DP, Jablonski-Westrich D, Holzmann B, Butcher EC: Role of α4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol 152:3282-3293, 1994
52. Crockett-Torabi E, Sulenbarger B, Smith CW, Fantorn JC: Activation of human neutrophils through L-selectin and Mac-1 molecules. J Immunol 154:2291-2302, 1995
53. Davis LS, Oppenheimer-Marks N, Bednarczyk JL, McIntyre BW, Lipsky PE: Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol 145:785-793, 1990
54. Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S: The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 144:4579-4586, 1990
55. Teague TK, Lazarovits AI, McIntyre BW: Integrin α4β7 costimulation of human peripheral blood T cell proliferation. Cell Adhes Commun 2:539-547, 1994
56. Dubey C, Croft M, Swain SL: Costimulatory requirements of naive CD4+ T cells: ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J Immunol 155:45-57, 1995
57. Roberts K, Yokoyama WM, Kenn PJ, Shevach EM: The vitronectin receptor serves as an accessory molecule for the activation of a subset of γ/δ T cells. J Exp Med 173:231-240, 1991
58. Udagawa T, Woodside DG, McIntyre BW: α4β1 (CD49d/CD29) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation. J Immunol 157:1965-1972, 1996
59. Yurochko AD, Liu DY, Eierman D, Haskill S: Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc Natl Acad Sci U S A 89:9034-9038, 1992
60. Romanic AM, Madri JA: The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol 125:1165-1178, 1994
61. Werb Z, Tremble PM, Behrendtsen O, Crowley E, Damsky CH: Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 109:877-889, 1989
62. Goetzl EJ, Banda MJ, Leppert D: Matrix metalloproteinases in immunity. J Immunol 156:1-4, 1996
63. Palmer DG: The anatomy of the rheumatoid lesion. Br Med Bull 51:286-295, 1995
64. Cutolo M, Sulli A, Barone A, Seriolo B, Accardo S: Macrophages, synovial tissue and rheumatoid arthritis. Clin Exp Rheumatol 11:331-339, 1993
65. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA: Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 137:1893-1896, 1986
66. Remmers EF, Sano H, Wilder RL: Platelet-derived growth factors and heparin-binding (fibroblast) growth factors in the synovial tissue pathology of rheumatoid arthritis. Semin Arthritis Rheum 21:191-199, 1991
67. Postigo AA, Sanchez-Madrid F: Adhesion and homing molecules. Transplant Proc 25:65-69, 1993
68. Pitzalis C, Kingsley G, Panayi G: Adhesion molecules in rheumatoid arthritis: role in the pathogenesis and prospects for therapy. Ann Rhuem Dis 53:287-288, 1994
69. Tak PP, Thurkow EW, Dana MR, Kluin PM, Smeets TJM, Meinders AE, Breedveld FC: Expression of adhesion molecules in early rheumatoid synovial tissue. Clin Immunol Immunopathol 77:236-242, 1995
70. Hale LP, Mart ME, McCollum DE, Nunley JA, Springer TA, Singer KH, Haynes BF: Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis Rheum 32:22-30, 1989
71. Johnson BA, Haines GK, Harlow LA, Koch AE: Adhesion molecule expression in human synovial tissue. Arthritis Rheum 36:137-146, 1993
72. Arroyo AG, Garcia-Vicuna R, Marazuela M, Yednock TA, Gonzalez-Amaro R, Sanchez-Madrid F: Expression and functional significance of an activation-dependent epitope of the β1 integrins in chronic inflammatory diseases. Eur J Immunol 25:1720-1728, 1995
73. Edwards JCW, Wilkinson LS, Speight P, Isenberg DA: Vascular cell adhesion molecule 1 and α4 and β1 integrins in lymphocyte aggregates in Sjögren's syndrome and rheumatoid arthritis. Ann Rheum Dis 52:806-811, 1993
74. Morales-Ducret J, Wayner E, Elices MJ, Alvaro-Gracia JM, Zvaifler NJ, Firestein GS: α4β1 integrin (VLA-4) ligands in arthritis: vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol 149:1424-1431, 1992
75. Kriegsmann J, Keyszer GM, Geiler T, Brauer R, Gay RE, Gay S: Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab Invest 72:209-214, 1995
76. Koch AE, Burrows JC, Haines GK, Carlos TM, Harlan JM, Leibovich SJ: Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest 64:313-320, 1991
77. El-Gabalawy H, Gallatin M, Vazeux R, Peterman G, Wilkins J: Expression of ICAM-r (ICAM-3), a novel counter-receptor for LFA-1, in rheumatoid and nonrheumatoid synovium: comparison with other adhesion molecules. Arthritis Rheum 37:846-854, 1994
78. Szekanecz Z, Haines GK, Lin TR, Harlow LA, Goerdt S, Rayan G, Koch AE: Differential distribution of intercellular adhesion molecules (ICAM-1, I CAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia: their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum 37:221-231, 1994
79. Kriegsmann J, Keyszer GM, Geiler T, Lagoo AS, Lagoo-Deenadayalan S, Gay RE, Gay S: Expression of E-selectin messenger RNA and protein in rheumatoid arthritis. Arthritis Rheum 38:750-754, 1995
80. To STT, Newman PM, Hyland VJ, Robinson BG, Schrieber L: Regulation of adhesion molecule expression by human synovial microvascular endothelial cells in vitro. Arthritis Rheum 39:467-477, 1996
81. Elices MJ, Tsai V, Strahl D, Goel AS, Tollefson V, Arrhenius T, Wayner EA, Gaeta FCA, Gikes JD, Firestein GS: Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 93:405-416, 1994
82. Wilkinson LS, Edwards JCW, Poston RN, Haskard DO: Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab Invest 68:82-88, 1993
83. Grober JS, Bowen BL, Ebling H, Athey B, Thompson CB, Fox DA, Stoolman LM: Monocyte-endothelial adhesion in chronic rheumatoid arthritis: in situ detection of selectin and integrin-dependent interactions. J Clin Invest 91:2609-2619, 1993
84. Issekutz AC, Issekutz TB: Monocyte migration to arthritis in the rat utilizes both CD11/CD18 and very late activation antigen 4 integrin mechanisms. J Exp Med 181:1197-1203, 1995
85. Szekanecz Z, Haines GK, Harlow LA, Shah MR, Hong TW, Fu R, Lin SJ-W, Koch AE: Increased synovial expression of the adhesion molecules CD66a, CD66b, and CD31 in rheumatoid and osteoarthritis. Clin Immunol Immunopathol 76:180-186, 1995
86. Van Dinther-Janssen ACHM, Kraal G, van Soesbergen R, Scheper FJ, Meijer CJLM: Immunohistological and functional analysis of adhesion molecule expression in the rheumatoid synovial lining layer: implications for synovial lining cell destruction. J Rheumatol 21:1998-2004, 1994
87. Issekutz TB, Issekutz AC: T lymphocyte migration to arthritic joints and dermal inflammation in the rat: differing migration patterns and the involvement of VLA-4. Clin Immunol Immunopathol 61:436-447, 1991
88. Wahl SM, Allen JB, Hines KL, Imamichi T, Wahl AM, Furcht LT, McCarthy JB: Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest 94:655-662, 1994
89. Hemler ME, Glass D, Coblyn JS, Jacobson JG: Very late activation antigens on rheumatoid synovial fluid T lymphocytes: association with stages of T cell activation. J Clin Invest 78:696-702, 1986
90. Takahashi H, Soderstrom K, Nilsson E, Kiessling R, Patarroyo M: Intrgrins and other adhesion molecules on lymphocytes from synovial fluid and peripheral blood of rheumatoid arthritis patients. Eur J Immunol 22:2879-2885, 1992
91. Kelleher D, Murphy A, Hall N, Omary MB, Kearns G, Long A, Casey EB: Expression of CD44 on rheumatoid synovial fluid lymphocytes. Ann Rheum Dis 54:566-570, 1995
92. Ueki Y, Eguchi K, Shimada H, Nakashima M, Ida H, Miyake S, Nagataki S, Tominaga Y: Increase in adhesion molecules on CD4+ cells and CD4+ cell subsets in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 21:1003-1010, 1994
93. Yakota A, Murata N, Saiki O, Shimizu M, Springer TA, Kishimoto T: High avidity state of leukocyte function-associated antigen-1 on rheumatoid synovial fluid T lymphocytes. J Immunol 155:4118-4124, 1995
94. Postigo AA, Garcia-Vicuna R, Diaz-Gonzalez F, Arroyo AG, de Landauri MO, Chi-Rosso G, Lobb RR, Laffon A, Sanchez-Madrid F: Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1). J Clin Invest 89:1445-1452, 1992
95. Lazarovits AI, Karsh J: Differential expression in rheumatoid synovium and synovial fluid of α4β7 integrin: a novel receptor for fibronectin and vascular cell adhesion molecule-1. J Immunol 151:6482-6489, 1993
96. Jorgensen C, Travaglio-Encinoza A, Bologna C, d'Angeac AD, Reme T, Sany J: Human mucosal lymphocyte marker expression in synovial fluid lymphocytes of patients with rheumatoid arthritis. J Rheumatol 21:1602-1607, 1994
97. Kadioglu A, Sheldon P: Adhesion of rheumatoid lymphocytes to mucosal endothelium: the gut revisited. Br J Rheumatol 35:218-225, 1996
98. Salmi M, Andrew DP, Butcher EC, Jalkanen S: Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms. J Exp Med 181:137-149, 1995
99. Humbría A, Díaz-González F, Campanero MR, Arroyo AG, Laffón A, González-Amaro R, Sánchez-Madrid F: Expression of L-selectin, CD43, and CD44 in synovial fluid neutrophils from patients with inflammatory joint diseases: evidence for a soluble form of L-selectin in synovial fluid. Arthritis Rheum 37:342-348, 1994
100. Issekutz AC, Issekutz TB: A major portion of polymorphonuclear leukocyte and T lymphocyte migration to arthritic joints in the rat is via LFA-1/MAC-l-independent mechanisms. Clin Immunol Immunopathol 67:257-263, 1993
101. Schall TJ, Bacon KB: Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 6:865-873, 1994
102. Kunkel SL, Lukacs N, Kasama T, Stricter RM: The role of chemokines in inflammatory joint disease. J Leukoc Biol 58:6-12, 1996
103. Brennan FM, Field M, Chu CQ, Feldmann M, Maini RN: Cytokine expression in rheumatoid arthritis. Br J Rheumatol 30 (suppl):76-80, 1991
104. Blue M-L, Conrad P, Webb DL, Sarr T, Macaro M: Interacting monocytes and synoviocytes induce adhesion molecules by a cytokine-regulated process. Lymphokine Cytokine Res 12:213-218, 1993
105. Bombara MP, Webb DL, Conrad P, Marlor CW, Sarr T, Ranges GE, Aune TM, Greve JM, Blue M-L: Cell contact between T cells and synovial fibroblasts causes induction of adhesion molecules and cytokines. J Leukoc Biol 54:399-406, 1993
106. Shimada H, Eguchi K, Ueki Y, Nakashima M, Yamashita I, Kawabe Y, Sukai M, Ida H, Aoyagi T, Nagataki S: Interleukin 4 increases human synovial cell expression of VCAM-1 and T cell binding. Ann Rheum Dis 53:601-607, 1994
107. Krzesicki RF, Fleming WE, Winterrowd GE, Hatfield CA, Sanders ME, Chin JE: T lymphocyte adhesion to human synovial fibroblasts: role of cytokines and the interaction between intercellular adhesion molecule 1 and CD11a/CD18. Arthritis Rheum 34:1245-1253, 1991
108. Wicks IP, Leizer T, Wawryk SO, Novotny JR, Hamilton J, Vitti G, Boyd AW: The effect of cytokines on the expression of MHC antigens and ICAM-1 by normal and transformed synoviocytes. Autoimmunity 12:13-19, 1992
109. Cicuttini FM, Martin M, Boyd AW: Cytokine induction of adhesion molecules on synovial type B cells. J Rheumatol 21:406-412, 1994
110. Lindsley HB, Smith DD, Cohick CB, Koch AE, Davis LS: Proinflammatory cytokines enhance human synoviocyte expression of functional intercellular adhesion molecule-1 (ICAM-1). Clin Immunol Immunopathol 68:311-320, 1993
111. Brennan FM: Role of cytokines in experimental arthritis. Clin Exp Immunol 97:1-3, 1994
112. Streiter RM, Standiford TJ, Huffnagle GB, Colletti LM, Lukacs NW, Kunkel SJ: 'The good, the bad, and the ugly:" The role of chemokines in models of human disease. J Immunol 156:3583-3586, 1996
113. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ: Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376:517-519, 1995
114. Takeda I, Kaise S, Nishimaki T, Kasukawa R: Soluble P-selectin in the plasma of patients with connective tissue diseases. Int Arch Allergy Immunol 105:128-134, 1994
115. Blann AD, Herrick A, Jayson MIV: Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Br J Rheumatol 34:814-819, 1995
116. Aoki S, Imai K, Yachi A: Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis. Scand J Immunol 38:485-490, 1993
117. Machold KP, Kiener HP, Graninger W, Graninger WB: Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 68:74-78, 1993
118. Wellicome SM, Kapahi P, Mason JC, Leranchu Y, Yarwook H, Haskaard KO: Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 92:412-418, 1993
119. Voskuyl AE, Martin S, Melchers I, Zwinderman AH, Weichselbraun I, Breedveld FC: Levels of circulating intercellular adhesion molecule-1 and -3 but not circulating endothelial leucocyte adhesion molecule are increased in patients with rheumatoid vasculitis. Br J Rheumatol 34:311-315, 1995
120. Mason JC, Kapahi P, Haskard DO: Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus: lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum 36:519-527, 1993
121. Kuryliszyn-Moskal A, Bernacka K, Klimiuk PA: Circulating intercellular adhesion molecule 1 in rheumatoid arthritis: relationship to systemic vasculitis and microvascular injury in nailfold capillary microscopy. Clin Rheumatol 15:367-373, 1996
122. Cush JJ, Rothlein R, Lindsley HB, Mainolfi EA, Lipsky PE: Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis. Arthritis Rheum 36:1098-1102, 1993
123. Koch AE, Turkiewicz W, Harlow LA, Pope RM: Soluble E-selectin in arthritis. Clin Immunol Immunopathol 69:29-35, 1993
124. Carson CW, Beall LD, Hunder GG, Johnson CM, Newman W: Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. J Rheumatol 20:809-814, 1993
125. Janssen BA, Luqmani RA, Ordon C, Hemingway IH, Bacon PA, Gearing AJH, Emery P: Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheumatol 33:1112-1116, 1994
126. Sfikakis PP, Charlalabopoulos D, Vayiopoulos G, Oglesby R, Sfikakis P, Tsokos GC: Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus. Clin Exp Rheumatol 12:5-9, 1994
127. Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CGM: Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbation in patients with systemic lupus erythematosus (SLE): a long term prospective study. Clin Exp Immunol 97:439-444, 1994
128. Mrowka C, Sieberth HG: Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure. Clin Nephrol 5:288-296, 1995
129. Mrowka C, Sieberth HG: Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosus and systemic lupus erythematosus. Clin Invest 72:762-768, 1994
130. Ihn H, Fujimoto M, Sato S, Kikuchi K, Igarashi A, Soma Y, Takehara K: Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma. J Am Acad Dermatol 31:591-595, 1994
131. Sfikakis PP, Tesar J, Baraf H, Lipnick R, Klippke G, Tsokos GC: Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin Immunol Immunopathol 68:88-92, 1993
132. Kiener H, Graninger W, Machold K, Aringer M, Graninger WB: Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin Exp Rheumatol 12:483-487, 1994
133. Gruschwitz MS, Hornstein OP, von den Driesch P; Correlation of , soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 38:184-189, 1995
134. Carson CW, Beall LD, Hunder GG, Johnson CM, Newman W: Soluble E-selectin is increased in inflammatory synovial fluid. J Rheumatol 21:605-611, 1994
135. 2 fragment of anti-E-selectin monoclonal antibody. Radiology 194:843-850, 1995
136. Chapman PT, Jamar F, Harrison AA, Binns RM, Peters AM, Haskard DO: Noninvasive imaging of E-selectin expression by activated endothelium in urate crystal-induced arthritis. Arthritis Rheum 37:1752-1756, 1994
137. FitzGerald O: Advances in understanding and novel therapeutic targets in inflammatory arthritis. Ir J Med Sci 164:4-11, 1995
138. Cronstein BN, Molad Y, Reibman J, Balakhane E, Levin RI, Weissmann G: Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest 96:994-1002, 1995
139. Cronstein BN, Eberle MA, Gruber HE, Levin RI: Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A 88:2441-2445, 1991
140. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G: Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148:2201-2206, 1992
141. Firestein GS, Bullough DA, Erion MD, Jimenez R, Ramirez-Weinhouse M, Barankiewicz J, Smith CW, Gruber HE, Mullane KM: Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor: the role of selectins. J Immunol 154:326-333, 1995
142. Gadangi P, Longaker M, Naime D, Levin RI, Recht PA, Montesinos MC, Buckley MT, Carlin G, Cronstein BN: The antiinflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J Immunol 156:1937-1941, 1996
143. Corkill MM, Kirkham BW, Haskard DO, Barbatis C, Gibson T, Panayi S: Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1. J Rheumatol 18:1453-1460, 1991
144. Newman PM, To SST, Robinson BG, Hyland VJ, Schrieber L: Effect of gold sodium thiomalate and its thiomalate component on the in vitro expression of endothelial cell adhesion molecules. J Clin Invest 94:1864-1871, 1994
145. Loetscher P, Dewald B, Baggiolini M, Seitz M: Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes: effects of anti-rheumatic drugs. Cytokine 6:162-170, 1994
146. Cronstein BN, Kimmel SC, Levin RI, Martiiuk F, Weissmann G: A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 89:9991-9995, 1992
147. Tessier PA, Cattaruzzi P, McColl SR: Inhibition of lymphocyte adhesion to cytokine-activated synovial fibroblasts by glucocorticoids involves the attenuation of vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 gene expression. Arthritis Rheum 39:226-234, 1996
148. Kubes P, Jutila M, Payne D: Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest 95:2510-2519, 1995
149. Harris JG, Flower RJ, Perretti M: Alteration of neutrophil trafficking by a lipocortin 1 N-terminus peptide, Eur J Pharmacol 279:149-157, 1995
150. Shimaoka M, Ikeda M, Iida T, Taenaka N, Yoshiya I, Honda T: Fucoidin, a potent inhibitor of leukocyte rolling, prevents neutrophil influx into phorbol-ester-induced inflammatory sites in rabbit lungs. Am J Respir Crit Care Med 153:307-311, 1996
151. Colgan SP, Parkos CA, McGuirk D, Brady HR, Papayianni AA, Frendl G, Madara JL: Receptors involved in carbohydrate binding modulate intestinal epithelial-neutrophil interactions. J Biol Chem 270:10531-10539, 1995
152. Jasin HE, Lightfoot E, Davis LS, Rothlein R, Faanes RB, Lipsky PE: Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules. Arthritis Rheum 35:541-549, 1992
153. Verdrengh M, Holmdahl R, Tarkawski A: Administration of antibodies to hyaluronan receptor (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand J Immunol 42:353-358, 1995
154. Bennett CF, Condon TP, Grimm S, Chan H, Chiang M-Y: Inhibition of endothelial cell adhesion molecule expression with antisense oligonuclcotides. J Immunol 152:3530-3540, 1994
155. Jakubowski A, Rosa MD, Bixler S, Lobb R, Burkly LC: Vascular cell adhesion molecule (VCAM)-Ig fusion protein defines distinct affinity states of the very late antigen-4 (VLA-4) receptor. Cell Adhes Commun 3:131-142, 1995
156. Jakubowski A, Ehrenfels BN, Pepinsky RB, Burkly LC: Vascular cell adhesion molecule-Ig fusion protein selectively targets activated α4-integrin receptors in vivo: inhibition of autoimmune diabetes in an adoptive transfer model in nonobese diabetic mice. J Immunol 155:938-946, 1995
157. Paulus HE, Egger MJ, Ward JR, Williams HJ, the Cooperative Systematic Studies of Rheumatic Diseases Group: Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 33:477-484, 1990
158. Tak PP, Taylor PC, Breedveld FC, Smeets TJM, Daha MR, Kluin PM, Meinders AE, Maini RN: Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 39:1077-1081, 1996
159. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110, 1994
160. Paleolog EM, Hunt M, Elliott MJ, Feldmann M, Maini RN, Woody JN: Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor a antibody in rheumatoid arthritis. Arthritis Rheum 39:1082-1091, 1996
161. Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA, Lipsky PE: Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 37:992-999, 1994
162. Davis LS, Kavanaugh AF, Nichols LA, Lipsky PE: Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis. J Immunol 154:3525-3537, 1995
163. Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS: Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis: modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol 155:5029-5037, 1995
164. Anderson DC, Springer TA: Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA1 and p 150,95 glycoproteins. Annu Rev Med 38:175-194, 1987